Further detail on the adverse events was not provided, but were all from patients who received preservative free methylprednisolone acetate (80 mg/mL) by injection, according to the FDA.
The FDA has recommended providers not administer any products from Main Street until further guidance is provided.
More Articles on Compounding Pharmacy Contamination:
FDA Warns Drugs From Florida Compounding Shop May Be Contaminated
New Sterile Compounding Guidelines Released
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.